1. Home
  2. DXR

DXR

Daxor Corporation

Logo Daxor Corporation

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Founded: 1970 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 45.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 2.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.41 EPS Growth: N/A
52 Week Low/High: $7.11 - $13.13 Next Earning Date: 01-01-0001
Revenue: $34,306,608 Revenue Growth: 10450.94%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: